While GLP-1 RAs have provided an important new weapon for those suffering from profound obesity, they unfortunately trigger the same counter-productive mechanisms as other weight-loss efforts, which rely on caloric restriction, resulting in muscle loss, which limits the fat loss and metabolic benefit
People with diabetes also need medication review because insulin, sulfonylureas, and appetite changes can interact in clinically important ways
for others, its more pronounced and distressing
Adequate fluid intake supports bowel regularity and reduces constipation risk
Tirzepatide was developed by Eli Lilly, resulting in a proprietary medication named Mounjaro
Tirzepatide has advantages over other peptides, demonstrating promising results